Human Cytomegalovirus Induces the Expression of the AMPKa2 Subunit to Drive Glycolytic Activation and Support Productive Viral Infection

Human Cytomegalovirus Induces the Expression of the AMPKa2 Subunit to Drive Glycolytic Activation and Support Productive Viral Infection

The human cytomegalovirus infection (HCMV) modulates cellular metabolism to support viral replication. Kinase Kinase Kinase Calcium / Calmodulin (CAMKK) and Protein activated amp (AMPK) regulates metabolic activation and has been found important for successful HCMV infections. Here, we explore the specific contributions of camkk isoforms and ampk subunit isoforms to make HCMV infection. Our results show that various ISOFORM camkk and AMPK contribute to infection in a unique way.

For example, Camkk1 is important for HCMV infection in low infection multiplicity, but can be used for AMPK activation during the earliest infection, which is suggested by our data more dependent on camkk2. Our results also show that HCMV specifically induces the expression of catalytic subunit ampka2 non-ubiquitous, which is found important for glycolytic activation mediated by HCMV and high titers infections. Furthermore, we found that glycolytic activation mediated ampk was important for infection, as an excessive expression of glut4, high-capacity glucose transporter, some saved viral replication in the face of the inhibition of Ampk.

Collectively, our data shows that HCMV infection selectively induces specific metabolic regulation kinase expression, relying on their activities to support glycolytic activation and productive infection. The important virus is a mandatory parasite to provide energy and molecular building blocks to the masses to produce a descendant of the infectious virus. The process that regulates the modulation of cellular resource viruses has emerged as critical for successful infections.

Here, we find that HCMV depends on two kinase isoforms to support infection, camkk1 and ampka2. We found that HCMV specifically induces ampka2 subunit expression to induce metabolic activation and encourage strong viral replication. These results indicate that HCMV has evolved a mechanism to target certain metabolic regulatory kinase subunits to support productive infections, thus providing insight into how HCMV hijacked cellular metabolism for replication, and explained the vulnerability of potential virus therapy.

Cytomegalovirus cervical reactivation, cytokine, and spontaneous premature birth in Kenyan women

Activation of cytomegalovirus genital reactivation (CMV) is common during the third trimester of pregnancy. We hypothesize, cervical CMV shedding can increase the risk of spontaneous premature birth (SPTB) through the release of inflammatory cytokines in the cervix. We conducted a nesting case control analysis to determine the relationship between shedding CMV and SPTB using data and samples from prospective cohort studies in West Kenya. Women delivered between 28 + 0 and 33 + 6 weeks of pregnancy are adjusted to the gestational age on the collection of samples to control delivered ≥37 + 0 weeks.

The Level of CMV DNA and Interleukin (IL) -1 Beta (β), IL-6, IL-8, and Necrosis Factor-Alpha (TNF-α) tumors are measured in the servix. We use conditional logistic regression to assess the relationship between shedding cmv, cervical cytokine levels, and SPTB. Among the 86 cases and 86 suitable controls, cmv cervical levels are not significantly related to the SPTB (Odds Ratio [or] = 1.23, 95% trust interval [CI] 0.59-2.56), but significantly associated With higher IL-6 cervical levels. (β = 0.15, 95% CI 0.02-0.29) and TNF-α (β = 0.14, 95% CI 0.01-0.27). In univariate analysis, higher SPTB opportunities are associated with higher cervical IL-6 levels (or = 1.54, 95% CI 1.00-2.38), but not with other cervical cytokines. In this Kenyan women’s cohort, we did not find a significant relationship between cervical and SPTB shedding before 34 weeks.

Letermovir prophylaxis is effective in preventing reactivation of cytomegalovirus after alogenic hematopoietic cell transplantation: real single world data data

Morbidity and mortality after alogenic hematopoietic cell transplants (ALLOHCT) are still basically influenced by Cytomegalovirus (CMV) reactivation. We evaluate 80 seropositive patients transplanted in a row between March 2018 and March 2019 who received the prophylaxis of the Letermovir (leave) from engraftment to day +100 and retrospectively compare it with 80 patients without allowing allograft between January 2017 and March 2018.

The end point of research This is a cumulative incidence (CI) Clinically significant CMV infection (CS-CMVI) defined as CMV reactivation which demands preemptive treatment or CMV disease. With 14% CI CS-CMVI on the day +100 (11 events) significantly lower in let the cohort compared to the control group (33 events, 41%; HR 0.29; p <0.001). While therapy with Foscarnet can be fully avoided in the Group Leave, 7 out of 80 patients in the control cohort receiving Foscarnet, producing 151 extra patients for foscarnet (p = 0.002). The overall survival of one year is 72% on the control arm vs. 84% in the arms (HR 0.75 [95% CI 0.43-1.30]; P <0.306). This study confirms the efficacy and security let’s for the CS-CMVI prophylaxis after ALLOHCT in real-world settings, resulting in significant patient benefits by reducing hospitalization needs and exposure to antivirus drugs that are potentially toxic for the treatment of CMV reactivation.

Human Cytomegalovirus Induces the Expression of the AMPKa2 Subunit to Drive Glycolytic Activation and Support Productive Viral Infection

Micrornas screening and validation and targets expressly expressed in hypertensive mice caused by cytomegalovirus infection

Introduction Some studies have suggested the relationship between Cytomegalovirus (CMV) infection and essential hypertension (eh). Micrornas (MIRNAS) plays an important role in developing EH by regulating specific target gene expression. However, a few are known about the role of MIRNA in uh induced by CMV. In this study, we compare the profile of Mirna’s expressions from samples from normal and murine cytomegalovirus (MCMV) -Infected C57BL / 6 mice using high-throughput sequencing analysis.

The method we collect thoracic aortic, heart tissue, and peripheral blood of twenty normal mice and twenty mice infected with MCMV. We identify Mirna which is expressly expressed in peripheral blood samples and predicts their target genes using bioinformatics tools. We then experimentally validated them using QRT-PCR and target genes with a double luciferase gene test test. The results we found 118 expressed by MIRNAs, including 9 MIRNAs was identified as potential hypertensive regulators induced by MCMV infection. We then validated the expression of two MIRAS candidates, MMU-MIR-1929-3P and MCMV-MIR-M01-4-5P, using QRT-PCR.

FBXO17 Blocking Peptide

DF13006-BP 1mg
EUR 234

anti- FBXO18 antibody

FNab03039 100µg
EUR 658.5
Description: Antibody raised against FBXO18

anti- FBXO22 antibody

FNab03041 100µg
EUR 702
Description: Antibody raised against FBXO22

anti- FBXO28 antibody

FNab03042 100µg
EUR 702
Description: Antibody raised against FBXO28

anti- FBXO32 antibody

FNab03044 100µg
EUR 606.3
Description: Antibody raised against FBXO32

anti- FBXO41 antibody

FNab03045 100µg
EUR 658.5
Description: Antibody raised against FBXO41

anti- FBXO43 antibody

FNab03046 100µg
EUR 702
Description: Antibody raised against FBXO43

FBXO17 ELISA KIT|Human

EF009580 96 Tests
EUR 826.8

Rat FBXO17 shRNA Plasmid

20-abx988576
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse FBXO17 shRNA Plasmid

20-abx974104
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Human FBXO17 shRNA Plasmid

20-abx964438
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

anti- FBXO2 antibody

FNab03040 100µg
EUR 606.3
Description: Antibody raised against FBXO2

anti- FBXO3 antibody

FNab03043 100µg
EUR 606.3
Description: Antibody raised against FBXO3

anti- FBXO5 antibody

FNab03047 100µg
EUR 658.5
Description: Antibody raised against FBXO5

anti- FBXO6 antibody

FNab03048 100µg
EUR 606.3
Description: Antibody raised against FBXO6

anti- FBXO7 antibody

FNab03049 100µg
EUR 702
Description: Antibody raised against FBXO7

anti- FBXO8 antibody

FNab03050 100µg
EUR 658.5
Description: Antibody raised against FBXO8

anti- FBXO9 antibody

FNab03051 100µg
EUR 658.5
Description: Antibody raised against FBXO9

FBXO17 Recombinant Protein (Rat)

RP200984 100 ug Ask for price

FBXO17 Recombinant Protein (Human)

RP011875 100 ug Ask for price

FBXO17 Recombinant Protein (Mouse)

RP133955 100 ug Ask for price

Anti-LMO7 / FBXO20 antibody

STJ70480 100 µg
EUR 430.8

Fbxo17 ORF Vector (Rat) (pORF)

ORF066996 1.0 ug DNA
EUR 607.2

FBXO17 ORF Vector (Human) (pORF)

ORF003959 1.0 ug DNA
EUR 114

Fbxo17 ORF Vector (Mouse) (pORF)

ORF044653 1.0 ug DNA
EUR 607.2

Fbxo17 sgRNA CRISPR Lentivector set (Rat)

K6558001 3 x 1.0 ug
EUR 406.8

Fbxo17 sgRNA CRISPR Lentivector set (Mouse)

K4857601 3 x 1.0 ug
EUR 406.8

FBXO17 sgRNA CRISPR Lentivector set (Human)

K0764701 3 x 1.0 ug
EUR 406.8

Fbxo17 3'UTR GFP Stable Cell Line

TU156413 1.0 ml Ask for price

FBXO17 3'UTR GFP Stable Cell Line

TU057783 1.0 ml
EUR 2799.6

Fbxo17 3'UTR GFP Stable Cell Line

TU254497 1.0 ml Ask for price

FBXO17 Protein Vector (Rat) (pPM-C-HA)

PV267984 500 ng
EUR 723.6

FBXO17 Protein Vector (Rat) (pPB-C-His)

PV267982 500 ng
EUR 723.6

FBXO17 Protein Vector (Rat) (pPB-N-His)

PV267983 500 ng
EUR 723.6

FBXO17 Protein Vector (Rat) (pPM-C-His)

PV267985 500 ng
EUR 723.6

FBXO17 Protein Vector (Human) (pPM-C-HA)

PV015835 500 ng
EUR 394.8

FBXO17 Protein Vector (Mouse) (pPM-C-HA)

PV178612 500 ng
EUR 723.6

FBXO17 Protein Vector (Human) (pPB-C-His)

PV015833 500 ng
EUR 394.8

FBXO17 Protein Vector (Human) (pPB-N-His)

PV015834 500 ng
EUR 394.8

FBXO17 Protein Vector (Human) (pPM-C-His)

PV015836 500 ng
EUR 394.8

FBXO17 Protein Vector (Mouse) (pPB-C-His)

PV178610 500 ng
EUR 723.6

FBXO17 Protein Vector (Mouse) (pPB-N-His)

PV178611 500 ng
EUR 723.6

FBXO17 Protein Vector (Mouse) (pPM-C-His)

PV178613 500 ng
EUR 723.6

FBXO17 3'UTR Luciferase Stable Cell Line

TU007783 1.0 ml
EUR 2799.6

Fbxo17 3'UTR Luciferase Stable Cell Line

TU106413 1.0 ml Ask for price

Fbxo17 3'UTR Luciferase Stable Cell Line

TU204497 1.0 ml Ask for price

Fbxo17 sgRNA CRISPR Lentivector (Rat) (Target 1)

K6558002 1.0 ug DNA
EUR 184.8

Fbxo17 sgRNA CRISPR Lentivector (Rat) (Target 2)

K6558003 1.0 ug DNA
EUR 184.8

Fbxo17 sgRNA CRISPR Lentivector (Rat) (Target 3)

K6558004 1.0 ug DNA
EUR 184.8

Fbxo17 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K4857602 1.0 ug DNA
EUR 184.8

Fbxo17 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K4857603 1.0 ug DNA
EUR 184.8

Fbxo17 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K4857604 1.0 ug DNA
EUR 184.8

FBXO17 sgRNA CRISPR Lentivector (Human) (Target 1)

K0764702 1.0 ug DNA
EUR 184.8

FBXO17 sgRNA CRISPR Lentivector (Human) (Target 2)

K0764703 1.0 ug DNA
EUR 184.8

FBXO17 sgRNA CRISPR Lentivector (Human) (Target 3)

K0764704 1.0 ug DNA
EUR 184.8

Human F-Box Protein 17 (FBXO17) ELISA Kit

abx387316-96tests 96 tests
EUR 1093.2

FBXO18 antibody

10R-1565 100 ug
EUR 614.4
Description: Mouse monoclonal FBXO18 antibody

FBXO21 antibody

10R-4071 100 ul
EUR 829.2
Description: Mouse monoclonal FBXO21 antibody

FBXO21 antibody

10R-4072 100 ul
EUR 829.2
Description: Mouse monoclonal FBXO21 antibody

FBXO21 antibody

10R-4073 100 ul
EUR 871.2
Description: Mouse monoclonal FBXO21 antibody

FBXO21 antibody

10R-4074 100 ul
EUR 829.2
Description: Mouse monoclonal FBXO21 antibody

FBXO21 antibody

10R-4075 100 ul
EUR 829.2
Description: Mouse monoclonal FBXO21 antibody

FBXO21 antibody

10R-4077 100 ul
EUR 829.2
Description: Mouse monoclonal FBXO21 antibody

FBXO21 antibody

10R-4078 100 ul
EUR 829.2
Description: Mouse monoclonal FBXO21 antibody

FBXO21 antibody

10R-4079 100 ul
EUR 829.2
Description: Mouse monoclonal FBXO21 antibody

FBXO31 antibody

10R-6939 100 ul
EUR 871.2
Description: Mouse monoclonal FBXO31 antibody

FBXO32 Antibody

31096-100ul 100ul
EUR 302.4

FBXO32 Antibody

31096-50ul 50ul
EUR 224.4

FBXO32 antibody

38459-100ul 100ul
EUR 302.4

FBXO11 antibody

38737-100ul 100ul
EUR 302.4

FBXO10 Antibody

39860-100ul 100ul
EUR 468

FBXO42 Antibody

39863-100ul 100ul
EUR 468

FBXO44 Antibody

39864-100ul 100ul
EUR 468

FBXO31 Antibody

37567-100ul 100ul
EUR 302.4

FBXO18 Antibody

40045-100ul 100ul
EUR 468

FBXO15 Antibody

40046-100ul 100ul
EUR 468

FBXO34 antibody

43487-100ul 100ul
EUR 302.4

FBXO34 antibody

43487-50ul 50ul
EUR 224.4

FBXO31 antibody

70R-2500 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO31 antibody raised against the middle region of FBXO31

FBXO24 antibody

70R-2787 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO24 antibody raised against the N terminal of FBXO24

FBXO25 antibody

70R-2788 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO25 antibody raised against the N terminal of FBXO25

FBXO21 antibody

70R-2799 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO21 antibody raised against the N terminal of FBXO21

FBXO11 antibody

70R-2809 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO11 antibody raised against the middle region of FBXO11

FBXO24 antibody

70R-2810 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO24 antibody raised against the middle region of FBXO24

FBXO24 antibody

70R-2811 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO24 antibody raised against the middle region of FBXO24

FBXO32 antibody

70R-9208 50 ug
EUR 560.4
Description: Affinity purified rabbit polyclonal FBXO32 antibody

Fbxo32 antibody

70R-9209 50 ug
EUR 560.4
Description: Affinity purified rabbit polyclonal Fbxo32 antibody

FBXO31 antibody

70R-9250 50 ug
EUR 560.4
Description: Affinity purified rabbit polyclonal FBXO31 antibody

Fbxo34 antibody

70R-9473 50 ug
EUR 560.4
Description: Affinity purified rabbit polyclonal Fbxo34 antibody

FBXO25 antibody

70R-1163 100 ug
EUR 452.4
Description: Rabbit polyclonal FBXO25 antibody raised against the C terminal of FBXO25

FBXO15 antibody

70R-17256 50 ul
EUR 522
Description: Rabbit polyclonal FBXO15 antibody

FBXO18 antibody

70R-17257 50 ul
EUR 522
Description: Rabbit polyclonal FBXO18 antibody

FBXO22 antibody

70R-17259 50 ul
EUR 522
Description: Rabbit polyclonal FBXO22 antibody

FBXO44 antibody

70R-17261 50 ul
EUR 522
Description: Rabbit polyclonal FBXO44 antibody

FBXO43 antibody

70R-12858 100 ul
EUR 548.4
Description: Affinity purified Rabbit polyclonal FBXO43 antibody

FBXO27 antibody

70R-3150 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO27 antibody raised against the middle region of FBXO27

FBXO28 antibody

70R-3153 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO28 antibody raised against the middle region of FBXO28

FBXO24 antibody

70R-2248 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO24 antibody raised against the N terminal of FBXO24

FBXO24 antibody

70R-2249 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO24 antibody raised against the middle region of FBXO24

FBXO10 antibody

70R-3607 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO10 antibody raised against the middle region of FBXO10

FBXO22 antibody

70R-3753 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO22 antibody raised against the middle region of FBXO22

FBXO16 antibody

70R-3782 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO16 antibody raised against the N terminal of FBXO16

FBXO16 antibody

70R-3783 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO16 antibody raised against the C terminal of FBXO16

FBXO36 antibody

70R-3784 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO36 antibody raised against the N terminal of FBXO36

FBXO28 antibody

70R-3792 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO28 antibody raised against the middle region of FBXO28

FBXO33 antibody

70R-3799 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO33 antibody raised against the middle region of FBXO33

FBXO15 antibody

70R-4393 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO15 antibody raised against the N terminal of FBXO15

FBXO39 antibody

70R-3430 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO39 antibody raised against the N terminal of FBXO39

FBXO39 antibody

70R-3431 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO39 antibody raised against the middle region of FBXO39

FBXO34 antibody

70R-3482 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO34 antibody raised against the middle region of FBXO34

FBXO42 antibody

70R-3602 50 ug
EUR 560.4
Description: Rabbit polyclonal FBXO42 antibody raised against the middle region of FBXO42

FBXO45 antibody

31960-100ul 100ul
EUR 302.4

FBXO45 antibody

31960-50ul 50ul
EUR 224.4

FBXO16 Antibody

47548-100ul 100ul
EUR 302.4

FBXO32 Antibody

ABD7075 100 ug
EUR 525.6

FBXO32 Antibody

1-CSB-PA996906
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against FBXO32. Recognizes FBXO32 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:5000, WB:1:200-1:1000, IHC:1:25-1:100

FBXO22 Antibody

DF12399 200ul
EUR 420

FBXO27 Antibody

DF13007 200ul
EUR 420

FBXO32 Antibody

DF7075 200ul
EUR 420

FBXO38 Antibody

DF15979 100ul
EUR 420

FBXO33 Antibody

DF15994 100ul
EUR 420

FBXO43 Antibody

DF16113 100ul
EUR 420

FBXO30 Antibody

DF14441 100ul
EUR 420

FBXO25 Antibody

DF14736 100ul
EUR 420

FBXO11 Antibody

DF15401 100ul
EUR 420

FBXO42 Antibody

DF15839 100ul
EUR 420

FBXO31 Antibody

DF15940 100ul
EUR 420

FBXO31 Antibody

1-CSB-PA093129
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against FBXO31. Recognizes FBXO31 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

FBXO38 Antibody

DF13772 100ul
EUR 420

FBXO10 Antibody

1-CSB-PA890915LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against FBXO10. Recognizes FBXO10 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:5000, IHC:1:500-1:1000, IF:1:50-1:200

FBXO31 Antibody

1-CSB-PA907885
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against FBXO31. Recognizes FBXO31 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

FBXO44 Antibody

1-CSB-PA872497LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against FBXO44. Recognizes FBXO44 from Human. This antibody is Unconjugated. Tested in the following application: ELISA

FBXO15 Antibody

1-CSB-PA843324LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against FBXO15. Recognizes FBXO15 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

FBXO30 Antibody

1-CSB-PA844709LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against FBXO30. Recognizes FBXO30 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200

FBXO25 Antibody

1-CSB-PA848401LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against FBXO25. Recognizes FBXO25 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200

FBXO22 Antibody

1-CSB-PA854115ESR1HU
  • EUR 266.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against FBXO22. Recognizes FBXO22 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

FBXO22 Antibody

1-CSB-PA854115ESR2HU
  • EUR 266.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against FBXO22. Recognizes FBXO22 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

FBXO40 Antibody

1-CSB-PA883385LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against FBXO40. Recognizes FBXO40 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

FBXO28 Antibody

1-CSB-PA889119LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against FBXO28. Recognizes FBXO28 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

FBXO44 Antibody

1-CSB-PA008509GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against FBXO44. Recognizes FBXO44 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA

FBXO15 Antibody

1-CSB-PA008483GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against FBXO15. Recognizes FBXO15 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB

FBXO18 Antibody

1-CSB-PA008486GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against FBXO18. Recognizes FBXO18 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

FBXO22 Antibody

1-CSB-PA008489GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against FBXO22. Recognizes FBXO22 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

FBXO24 Antibody

1-CSB-PA008491LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against FBXO24. Recognizes FBXO24 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:1000-1:5000

FBXO32 Antibody

R34914-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: F-box protein 32

FBXO43 Antibody

R35015-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: F-box protein 43, early mitotic inhibitor 2, EMI2

FBXO44 Antibody

R33107-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: F-box protein 44

Rat F box only protein 17(FBXO17) ELISA kit

E02F0279-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rat F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat F box only protein 17(FBXO17) ELISA kit

E02F0279-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rat F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat F box only protein 17(FBXO17) ELISA kit

E02F0279-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rat F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig F box only protein 17(FBXO17) ELISA kit

E07F0279-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Porcine F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig F box only protein 17(FBXO17) ELISA kit

E07F0279-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Porcine F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig F box only protein 17(FBXO17) ELISA kit

E07F0279-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Porcine F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog F box only protein 17(FBXO17) ELISA kit

E08F0279-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Canine F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog F box only protein 17(FBXO17) ELISA kit

E08F0279-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Canine F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog F box only protein 17(FBXO17) ELISA kit

E08F0279-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Canine F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat F box only protein 17(FBXO17) ELISA kit

E06F0279-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Goat F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat F box only protein 17(FBXO17) ELISA kit

E06F0279-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Goat F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat F box only protein 17(FBXO17) ELISA kit

E06F0279-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Goat F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

FBXO17 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV665293 1.0 ug DNA
EUR 616.8

FBXO17 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV665297 1.0 ug DNA
EUR 616.8

FBXO40 Antibody (HRP)

20-abx311700
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

FBXO44 Antibody (HRP)

20-abx311174
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

FBXO15 Antibody (HRP)

20-abx309699
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Mouse F box only protein 17(FBXO17) ELISA kit

E03F0279-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Mouse F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse F box only protein 17(FBXO17) ELISA kit

E03F0279-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Mouse F box only protein 17(FBXO17) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Furthermore, the dual-luciferase reporter gene test revealed that the area 3′-untranslated (UTR) endothelin A receptor (Ednra) MRNA contains a binding site for MMU-MIR-1929-3P. Collectively, our data shows that MCMV infection can increase blood pressure and reduce MMU-MIR-1929-3P expression in C57BL / 6. In addition, we find that MMU-MIR-1929-3P targets 3 ‘UTR from MRNA Ednra. Conclusion This new regulation axis can help develop a new approach to clinical prevention and control eh.

Leave A Comment